AQQRF (Aquarius Surgical Technologies) Cyclically Adjusted Book per Share: $-0.06 (As of Dec. 2025)


What is Aquarius Surgical Technologies Cyclically Adjusted Book per Share?

Aquarius Surgical Technologies AQQRF Cyclically Adjusted Book per Share is $-0.06 as of Dec. 2025. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Aquarius Surgical Technologies's adjusted book value per share for the three months ended in Dec. 2025 was $-0.170. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-0.06 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 20.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 15.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Aquarius Surgical Technologies was 21.20% per year. The lowest was -1.00% per year. And the median was 9.55% per year.

As of today (2026-07-04), Aquarius Surgical Technologies's current stock price is $0.0042. Aquarius Surgical Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was $-0.06. Aquarius Surgical Technologies's Cyclically Adjusted PB Ratio of today is .


Aquarius Surgical Technologies  (OTCPK:AQQRF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Aquarius Surgical Technologies Cyclically Adjusted Book per Share Related Terms


Aquarius Surgical Technologies Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Aquarius Surgical Technologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aquarius Surgical Technologies Cyclically Adjusted Book per Share Chart

Aquarius Surgical Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.34 -0.03 -0.68 -0.03 -0.04

Aquarius Surgical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.04 -0.03 -0.07 -0.06

AQQRF vs ABT, SYK, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Aquarius Surgical Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aquarius Surgical Technologies Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aquarius Surgical Technologies's Cyclically Adjusted PB Ratio falls into.



Aquarius Surgical Technologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aquarius Surgical Technologies's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.17/130.3700*130.3700
=-0.170

Current CPI (Dec. 2025) = 130.3700.

Aquarius Surgical Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201603 -0.541 101.054 -0.698
201606 -0.556 102.002 -0.711
201609 -0.552 101.765 -0.707
201612 -0.546 101.449 -0.702
201703 0.223 102.634 0.283
201706 0.205 103.029 0.259
201709 0.246 103.345 0.310
201712 0.214 103.345 0.270
201803 0.005 105.004 0.006
201806 0.010 105.557 0.012
201809 -0.002 105.636 -0.002
201812 -0.013 105.399 -0.016
201903 -0.017 106.979 -0.021
201906 -0.011 107.690 -0.013
201909 -0.023 107.611 -0.028
201912 -0.018 107.769 -0.022
202003 -0.022 107.927 -0.027
202006 -0.033 108.401 -0.040
202009 -0.045 108.164 -0.054
202012 -0.055 108.559 -0.066
202103 -0.083 110.298 -0.098
202106 -0.094 111.720 -0.110
202109 -0.097 112.905 -0.112
202112 -0.102 113.774 -0.117
202203 -0.107 117.646 -0.119
202206 -0.112 120.806 -0.121
202209 -0.113 120.648 -0.122
202212 -0.097 120.964 -0.105
202303 -0.102 122.702 -0.108
202306 -0.110 124.203 -0.115
202309 -0.113 125.230 -0.118
202312 -0.118 125.072 -0.123
202403 -0.123 126.258 -0.127
202406 0.000 127.522 0.000
202409 -0.135 127.285 -0.138
202412 -0.135 127.364 -0.138
202503 -0.146 129.181 -0.147
202506 -0.134 129.892 -0.134
202509 -0.154 130.290 -0.154
202512 -0.170 130.370 -0.170

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-0.06 mean?
Aquarius Surgical Technologies (AQQRF) has a Cyclically Adjusted Book per Share of $-0.06 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Aquarius Surgical Technologies and its competitors.
Is Aquarius Surgical Technologies' Cyclically Adjusted Book per Share too high?
Aquarius Surgical Technologies' current Cyclically Adjusted Book per Share is $-0.06.
How does Aquarius Surgical Technologies' Cyclically Adjusted Book per Share compare to ABT and SYK?
Aquarius Surgical Technologies' Cyclically Adjusted Book per Share of $-0.06 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Aquarius Surgical Technologies and its competitors. Aquarius Surgical Technologies's current Cyclically Adjusted Book per Share is $-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current Cyclically Adjusted Book per Share of $-0.06. The current Cyclically Adjusted Book per Share is $-0.06. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current Cyclically Adjusted Book per Share is $-0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquarius Surgical Technologies Business Description

Other Exchanges ASTI:Canada
Address 89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.